Recurrent Melanoma Active Not Recruiting Phase 1 Trials for DB01590 (Everolimus)

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs